ASTRO Annual Meeting

Healio.com brings you the highlights from the American Society for Radiation Oncology Annual Meeting. Refer back to this page often to read the latest news from ASTRO, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting News CoverageVideo

VIDEO: Defibrotide effective, well tolerated in patients with hepatic veno-occlusive disease

January 3, 2016
ORLANDO, Fla. — Paul G. Richardson, MD, summarizes updated results of a trial presented at the ASH Annual Meeting and Exposition that…
Meeting News CoverageVideo

VIDEO: ASH features ‘exciting’ research in myeloproliferative neoplasms

January 2, 2016
ORLANDO, Fla. — Aaron Gerds, MD, discusses key research related to myeloproliferative neoplasms presented at the ASH Annual Meeting and…
Meeting News CoverageVideo

VIDEO: ASH showcases ‘dramatic, exciting advances’ in myeloma

December 29, 2015
ORLANDO, Fla. — Damian Green, MD, assistant professor at Seattle Cancer Care Alliance and University of Washington, offers insights into key…
Meeting News CoveragePerspective

Interim PET scans predict relapse of non-bulky early-stage Hodgkin’s lymphoma

December 22, 2015
ORLANDO, Fla. — Interim PET scans served as a biomarker for relapse in patients with non-bulky, stage I to stage II Hodgkin’s lymphoma…
Meeting News Coverage

Eloctate effective in prevention of target joint bleeding

December 21, 2015
Patients with severe hemophilia A who took Eloctate prophylactically experienced reduced annualized bleeding rates overall and in target joints…
Meeting News CoveragePerspective

Eltrombopag increases rate of hematologic response in severe aplastic anemia

December 21, 2015
ORLANDO, Fla. — The addition of eltrombopag to immunosuppressive treatment increased complete hematologic response rates in patients with…
Meeting News Coverage

Idelalisib combination reduces risk for progression, death in refractory CLL

December 18, 2015
ORLANDO, Fla. — The addition of idelalisib to bendamustine and rituximab prolonged PFS and OS among patients with relapsed/refractory chronic…
In the JournalsPerspective

Brentuximab vedotin combinations yield encouraging response rates in elderly Hodgkin’s lymphoma

December 18, 2015
ORLANDO, Fla. — Brentuximab vedotin conferred 100% objective response rates when combined with dacarbazine or bendamustine for the first-line…
Meeting News CoveragePerspective

Early PET scans guide de-escalation of therapy for advanced Hodgkin’s lymphoma

December 17, 2015
ORLANDO, Fla. — PET scans performed following two cycles of the chemotherapeutic regimen BEACOPP can be safely used to guide subsequent…
Meeting News CoveragePerspective

Depression prior to HSCT linked to increased mortality, GVHD risk

December 17, 2015
ORLANDO, Fla. — A depression diagnosis prior to allogeneic hematopoietic stem cell transplantation appeared associated with a greater risk for…